A case of macrophage activation syndrome developing in a patient with chronic granulomatous disease-associated colitis

J Pediatr Hematol Oncol. 2014 Apr;36(3):e169-72. doi: 10.1097/MPH.0b013e31828e5dae.

Abstract

Although macrophage activation syndrome (MAS) develops in some patients with chronic granulomatous disease (CGD), all of the reported cases have been associated with pathogenic microbial infections. We report a 2-year-old boy with CGD-associated colitis who suffered from MAS without any clinical signs of a microbial infection. He was treated with 1 course of methylprednisolone pulse therapy and the clinical symptoms improved; however, the colitis was difficult to control even with immunosuppressive drugs, and he eventually required hematopoietic stem cell transplantation 1 year after the onset of MAS. It is likely that MAS develops in patients with CGD colitis independent of microbial infections.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Inflammatory Agents / therapeutic use
  • Child, Preschool
  • Colitis / complications*
  • Colitis / drug therapy
  • Colitis / pathology
  • Combined Modality Therapy
  • Granulomatous Disease, Chronic / complications*
  • Granulomatous Disease, Chronic / drug therapy
  • Granulomatous Disease, Chronic / pathology
  • Hematopoietic Stem Cell Transplantation*
  • Humans
  • Macrophage Activation Syndrome / etiology*
  • Macrophage Activation Syndrome / pathology
  • Macrophage Activation Syndrome / therapy
  • Male
  • Methylprednisolone / therapeutic use*
  • Prognosis

Substances

  • Anti-Inflammatory Agents
  • Methylprednisolone